Notice Regarding Termination of Capital and Business Alliance with OPTiM Corporation and Full Repayment of Bonds
Central Medience has terminated its capital and business alliance with OPTiM and fully repaid bonds totaling 330 million yen.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 02:00
Central Medience Co., Ltd. (Head Office: Minato-ku, Tokyo; Representative Director: Ryutaro Nakagawa; hereinafter referred to as "the Company") announces that the capital and business alliance with OPTiM Corporation (Tokyo Head Office: Minato-ku, Tokyo; Representative Director and President: Shunji Sugaya; hereinafter referred to as "OPTiM") which was announced on May 15, 2025, has been terminated as of today, March 31, 2026 (Tuesday).
In conjunction with this, the full repayment of the bonds totaling 330 million yen, which were issued in relation to the said alliance, has also been completed as of today. The impact of this matter on the Company's financial condition and future business operations is minor and does not have a significant impact on the Company's financial base.
1. Background of this Review
The Company has been broadly exploring the possibility of collaboration with external partners to enhance its management and operational support for medical institutions.
As part of this initiative, we proceeded with the capital and business alliance with OPTiM. However, after carefully examining the discussions, considerations, and progress since the commencement of the alliance, and in light of the recent rapid advancements in generative AI and changes in the technological environment, we have concluded that a system where the Company leads decision-making and business promotion, rather than relying on an external system, is more appropriate for providing prompt and effective support to medical institutions.
Therefore, the Company has determined that there is limited rationale for continuing the said alliance at this time, and it has been terminated as of today by mutual agreement.
2. The Company's Basic Policy
The Company's policy is to appropriately and timely address the necessity of continuing capital and business alliances, consignment agreements, bond subscriptions, and other transactional relationships, without being bound by form or past circumstances, based on their concrete usefulness, effectiveness, and feasibility for supporting hospital management. Management decisions will be made based on whether they lead to the provision of concrete value to our client medical institutions.
Moving forward, we will continue to prioritize measures that contribute to maximizing the value provided to medical institutions, taking into comprehensive consideration the business growth of our group, the value provided to our client medical institutions, and capital efficiency.
3. Future Policy
As professionals in hospital management support, our group will continue to further strengthen the back-office support required by medical institutions. We currently provide various services supporting hospital operations, such as the provision of medical supplies, human resource support, finance, and cleaning services, to over 900 medical institutions nationwide.
We will continue to strengthen these support functions and contribute to the sustainable and stable operation of medical institutions under our philosophy of "Not stopping medical care."
About Central Medience Co., Ltd.
Founded in 2018, Central Medience Co., Ltd. operates under the management philosophy of "Not stopping medical care." As a Medical Integrator®, we provide all necessary back-office services for the medical field. To ensure the continuous provision of high-quality medical care, we aim to optimize medical management by allowing healthcare professionals to focus on medical practice while we support their back-office operations. We protect the future of medicine through multifaceted support, including Medical Delivery (medical supplies, personnel, cleaning), Medical Services (management consulting, PR support), and Medical Finance (factoring specialized for the medical industry).
Company Overview of Central Medience Co., Ltd.
Company Name: Central Medience Co., Ltd.
Location: 8F, Toranomon Twin Building East, 2-10-1 Toranomon, Minato-ku, Tokyo
Representative Director: Ryutaro Nakagawa
URL:
Central Medience: https://centralmedience.com/
美STAR (BiSTAR): https://beautystar.jp/
M&A Medical: https://mandamedical.centralmedience.com/
Medical Crew: https://career.centralmedience.com/crew/
Haken no Kaigo: https://career.centralmedience.com/kaigohaken/
Central Medience Payments: https://payments.centralmedience.com/
Central Medience Supply: https://cms.centralmedience.com/
Medical Mall: https://medicalmall.shop/
● We are currently recruiting for the following positions due to business expansion.
FAQ
When was the capital and business alliance with OPTiM Corporation terminated?
It was terminated as of March 31, 2026 (Tuesday).
Were the bonds repaid in conjunction with the termination of the alliance?
Yes, the full repayment of the bonds totaling 330 million yen, which were issued in relation to the alliance, has also been completed as of today.
What is the impact of the alliance termination on the company's financial condition?
The impact of this matter on the Company's financial condition and future business operations is minor and does not have a significant impact on the Company's financial base.
What is the background for reviewing the alliance?
In light of the recent rapid advancements in generative AI and changes in the technological environment, we concluded that a system where the Company leads decision-making and business promotion, rather than relying on an external system, is more appropriate for providing prompt and effective support to medical institutions.
What is the future business policy?
As professionals in hospital management support, our group will continue to further strengthen the back-office support required by medical institutions. Under our philosophy of "Not stopping medical care," we will contribute to the sustainable and stable operation of medical institutions.